Insider Buying: Pro Medicus (ASX:PME) Insider Purchases A$99,815.17 in Stock

Pro Medicus Limited (ASX:PME) insider Deena Shiff acquired 788 shares of the business’s stock in a transaction on Friday, February 13th. The stock was acquired at an average price of A$126.67 per share, for a total transaction of A$99,815.17.

Pro Medicus Stock Performance

The company has a debt-to-equity ratio of 1.10, a current ratio of 5.98 and a quick ratio of 4.39. The firm has a market cap of $29.16 billion, a price-to-earnings ratio of 351.99, a price-to-earnings-growth ratio of 3.87 and a beta of 0.56.

Pro Medicus Dividend Announcement

The business also recently declared a Interim dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 19th will be issued a dividend of $0.32 per share. This represents a dividend yield of 27.0%. The ex-dividend date of this dividend is Wednesday, February 25th. Pro Medicus’s dividend payout ratio (DPR) is presently 56.41%.

About Pro Medicus

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.